Integrity Bio, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Integrity Bio, Inc. - overview
Established
2003
Location
Camarillo, CA, US
Primary Industry
Biotechnology
About
Based in California, US, and founded in 2003 by Dr. Byeong Chang, Integrity Bio, Inc. is a biotechnology company that develops protein formulation. In 2021, Curia, formerly known as AMRI, has entered into a definitive agreement to acquire the company.
Integrity Bio is a developer and manufacturer of biopharmaceutical products focused on protein formulation and fill-finish services. The company offers hard-to-formulate products in liquid and lyophilized forms. The company is combining with Curia, in a transaction subject to the standard and customary closing conditions and is expected to close in the third quarter of 2021, and aims to develop the company's biologics drug product formulation to expand its ability to meet customers’ needs.
Current Investors
Curia Inc.
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy
Website
www.integritybio.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Integrity Bio, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Integrity Bio, Inc. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.